Publication | Closed Access

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer

Derivative ApigeninMedicineOncogenic AgentImmunologyTumor ImmunityInducible Pd-l1 ExpressionImmune Checkpoint InhibitorKras-mutant Lung CancerTumor SuppressorCancer BiologyCell BiologyLung CancerTumor Biology